These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3312080)

  • 1. Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.
    Daidone MG; Silvestrini R; Zaffaroni N; Grignolio E; Landoni F
    Invest New Drugs; 1987; 5(3):245-50. PubMed ID: 3312080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.
    Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
    Anticancer Res; 1990; 10(3):805-11. PubMed ID: 2195988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
    Jones M; Siracky J; Kelland LR; Harrap KR
    Br J Cancer; 1993 Jan; 67(1):24-9. PubMed ID: 8427780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
    Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
    Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
    Hrubisko M; Ujházy V
    Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.
    Kelland LR; Jones M; Abel G; Valenti M; Gwynne J; Harrap KR
    Cancer Chemother Pharmacol; 1992; 30(1):43-50. PubMed ID: 1586979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of second generation platinum cytostatics on mammalian cell proliferation.
    Keprtová J; Smutná A; Minárová E; Vrána O
    Neoplasma; 1990; 37(2):121-9. PubMed ID: 2188163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
    Dodion P; Sanders C; Georges P; Kenis Y
    Cancer Chemother Pharmacol; 1988; 22(1):80-2. PubMed ID: 3293841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.
    Perez RP; Perez KM; Handel LM; Hamilton TC
    Cancer Chemother Pharmacol; 1992; 29(6):430-4. PubMed ID: 1568285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.
    Russell J; Adam J; Wheldon TE; Kaye SB
    Cancer Chemother Pharmacol; 1989; 23(2):111-4. PubMed ID: 2535968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of carboplatin].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1949-58. PubMed ID: 2203318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC; Barnes D; Erickson LC
    Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells.
    O'Hara JA; Douple EB; Richmond RC
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1419-22. PubMed ID: 3531116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.